Category: C.R. BardSyndicate content

Bard still on the hook for its share of $5m pelvic mesh verdict

November 20, 2014 by Brad Perriello

A California appeals court upholds a $5 million judgment against C.R. Bard and the surgeon involved in a product liability lawsuit filed over its Avaulta pelvic mesh.

Bard still on the hook for its share of $5m pelvic mesh verdict

Manufacturers, medical societies team up for IVC filter study

November 13, 2014 by Brad Perriello

Manufacturers of inferior vena cava filters and 2 medical societies team up for a large-scale study of the pulmonary embolism preventers, 4 years after an FDA warning about the devices.

Manufacturers, medical societies team up for IVC filter study

The Society of Interventional Radiology, the Society for Vascular Surgery and 7 medical device companies are teaming up for the 1st large-scale study of inferior vena cava filters, 4 years after an FDA warning that the devices might dislodge or fracture.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Bard's Clearstream subsidiary adds 200 jobs in Ireland

November 12, 2014 by Brad Perriello

The Clearstream Technologies subsidiary acquired 3 years ago by C.R. Bard is reportedly expanding in Ireland, adding 200 jobs at its Enniscorthy plant.

Report: Bard's Clearstream subsidiary adds 200 jobs in Ireland

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Boston Scientific, Bard CEOs cool on consolidation

October 23, 2014 by Brad Perriello

The CEOs of medical device companies Boston Scientific and C.R. Bard are cool on the consolidation trend in medtech, saying they don't see the need for mega-deals to grow their businesses.

Boston Scientific, Bard CEOs cool on consolidation

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bard shares gain on nearly 50% earnings rise

October 23, 2014 by Brad Perriello

C.R. Bard reports a 3rd-quarter earnings gain of nearly 50% and raises its guidance for the rest of the year, sending share prices up this morning on Wall Street.

Bard shares gain on nearly 50% earnings rise

C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Supreme Court declines to hear appeal by Mirowski Family Ventures | Medtech legal news for the week of October 20, 2014

October 20, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Supreme Court passes on Mirowski-Medtronic patent case; Medtronic can't shake shareholders lawsuit over Infuse; FDA strikes out again in Prevor drug-or-device case; Ex-Bard, BD engineer gets 18 months for stealing trade secrets; Appeals court: Fujifilm Medical executive wasn't fired for not being Japanese

Supreme Court passes on Mirowski-Medtronic patent case

October 15, 2014 by Val Kennedy

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp